Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–5 of 5 results
Advanced filters: Author: Markus Peck-Radosavljevic Clear advanced filters

  • A major barrier to hepatitis C treatment uptake and delivery is the association of this therapy with frequent, and at times serious, adverse effects. This Review article provides a comprehensive literature review that systematically describes the adverse effects of Peg-IFN-α and ribavirin on various organ systems and, more importantly, recommends consensus approaches to managing those effects.

    • Mark S. Sulkowski
    • Curtis Cooper
    • Olav Dalgard
    Reviews
    Nature Reviews Gastroenterology & Hepatology
    Volume: 8, P: 212-223

  • In hepatocellular carcinoma driven by non-alcoholic steatohepatitis, aberrant T cell activation and impaired immune surveillance seem to make hepatocellular carcinoma less responsive to anti-PD1 or anti-PDL1 immunotherapy.

    • Dominik Pfister
    • Nicolás Gonzalo Núñez
    • Mathias Heikenwalder
    ResearchOpen Access
    Nature
    Volume: 592, P: 450-456

  • In this Consensus Statement, an international panel of experts present an overview of the latest developments in the field of cholangiocarcinoma. A set of consensus recommendations and research priorities is provided.

    • Jesus M. Banales
    • Pedro M. Rodrigues
    • Victor Lopez-Lopez
    Reviews
    Nature Reviews Gastroenterology & Hepatology
    Volume: 23, P: 65-96